NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘cancer’

29 August 2014

Leukemia & Lymphoma Society in $6.9m Series B for blood cancer specialist OncoPep

test-tubes-1-149744-m New and existing investors have laid down $6.9m Series B funding for blood cancer-fighting company OncoPep.

28 August 2014

RA Capital, Redmile in huge $55m Series C for cancer-fighting biotech business

cancer juno RA Capital Management and Redmile Group were among 11 new investors in a $55m Series C financing round for biotech company Bellicum Pharmaceuticals.

26 August 2014

Gimv exits Covagen after six years

covagen Investment firm Gimv has exited its portfolio company Covagen to an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson after more than six years.

12 August 2014

Thiel’s Mithril Capital leads $15m round for cancer treatment company MagForce USA

MagForce Paypal co-founder Peter Thiel’s late-stage investment fund Mithril Capital has led a $15m financing round for nanomedicine-focused anti-cancer device maker MagForce USA.

7 August 2014

Venture capital-backed Juno Therapeutics raises $134m Series B

cancer juno Venture capital-backed biotechnology startup Juno Therapeutics has raised $134m in its Series B round to fund the development of its immunotherapies for cancer.

25 June 2014

Oncology focus pays off, says Nextech CEOp

alps For life sciences venture firms, it is riskier to have a broad focus than targeting a specific segment of the sector, according to Nextechinvest founding partner and CEO Alfred Scheidegger.

23 June 2014

Definiens raises €15m to expand into digital tissue diagnostics

analysis European venture capital firm Wellington Partners has led a €15m growth financing round for German digital pathology image analysis and digital tissue diagnostics specialist Definiens.

21 May 2014

Venture capital-backed Kite Pharma files for IPO

cancer band pink_sq Venture capital-backed biopharmaceutical startup Kite Pharma has filed for an IPO.

12 May 2014

Mérieux joins Novartis, others in $21m ImaginAb Series B round

news_biotech_lrg Novartis Ventures has taken part in a $21m syndicated Series B round for clinical-stage biotech business ImaginAb.

8 May 2014

NEA joins Aisling, OrbiMed to back cancer treatment business Loxo with $24m

life science test tube_sq Venture capital major New Enterprise Associates has led a $24m Series B financing round for cancer-focused biopharmaceutical business Loxo Oncology.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014